vimarsana.com
Home
Live Updates
Exact Sciences (EXAS) Q4 2023 Earnings Call Transcript : vimarsana.com
Exact Sciences (EXAS) Q4 2023 Earnings Call Transcript : vimarsana.com
Exact Sciences (EXAS) Q4 2023 Earnings Call Transcript
EXAS earnings call for the period ending December 31, 2023.
Related Keywords
Seattle ,
Washington ,
United States ,
Italy ,
Phoenix ,
Arizona ,
New York ,
Japan ,
Germany ,
Canada ,
San Diego ,
California ,
Americans ,
Matt Sykes ,
Brandon Couillard Jefferies ,
Subbu Nambi Guggenheim ,
Andrew Brackmann William Blair ,
Jeff Elliott ,
Kevin Conroy ,
Brandon Couillard ,
Vijay Kumar Evercore ,
Puneet Souda ,
Dan Brennan ,
Subbu Nambi ,
Andrew Cooper ,
Doug Schenkel ,
Everett Cunningham ,
Puneet Souda Leerink ,
Patrick Donnelly Citi ,
Andrew Cooper Raymond James ,
Raymond James ,
Brian Baranick ,
Mark Massaro ,
William Blair ,
Dan Leonard ,
Vijay Kumar ,
Matt Sykes Goldman Sachs ,
Jack Meehan ,
Andrew Brackmann ,
Nate Harrill ,
Dan Arias ,
Patrick Donnelly ,
Catherine Schulte ,
Wolfe Research ,
Nephron Research ,
Dan Arias Stifel Financial Corp ,
Goldman Sachs ,
Broad Institute ,
Jack Meehan Nephron Research Analyst ,
Doug Schenkel Wolfe Research Analyst ,
Company Analyst ,
Exact Sciences ,
Exact Science ,
Motley Fool Stock Advisor ,
Stock Advisor ,
Chief Executive ,
Chief Operating ,
New Year ,
Labor Day ,
Resolution Bioscience ,
Medicare Advantage ,
Precision Oncology ,
New York State ,
Chief Commercial ,
Stifel Financial ,
General Manager ,
Leerink Partners ,
Guggenheim Partners ,
Xact Sciences ,
Evin Conroy ,
Eff Elliott ,
Hief Executive Officer ,
Verett Cunningham ,
Oug Schenkel ,
Recision Oncology ,